Effect of Vitamin D Supplementation on Skeletal Muscle Volume and Strength in Patients with Decompensated Liver Cirrhosis Undergoing Branched Chain Amino Acids Supplementation: A Prospective, Randomized, Controlled Pilot Trial.

Background: Sarcopenia worsens patient prognoses in chronic liver disease. This study aimed to elucidate the effects of vitamin D supplementation on skeletal muscle volume and strength in patients with decompensated cirrhosis.

Methods: Thirty-three patients were entered into the study based on the criteria and then randomly assigned to two groups: Group A ( = 17), the control group, and Group B ( = 16), those who received oral native vitamin D3 at a dose of 2000 IU once a day for 12 months.

Results: SMI values in Group B were significantly increased at 12 months (7.64 × 10). The extent of changes in the SMI and grip strength in Group B were significantly greater than that in Group A at 12 months ( = 2.57 × 10 and 9.07 × 10). The median change rates in the SMI were +5.8% and the prevalence of sarcopenia was significantly decreased from 80.0% (12/15) to 33.3% (5/15; = 2.53 × 10) in Group B.

Conclusions: Vitamin D supplementation might be an effective and safe treatment option for patients with decompensated cirrhosis to increase or restore the skeletal muscle volume and strength or prevent the muscle volume and strength losses.